Another study showed that hsa-miR-29-3p was expressed at low levels in nasopharyngeal carcinoma and could target COL1A1 to improve the radiosensitivity of nasopharyngeal carcinoma cells [29]. The gene discussed is COL1A1; the disease is nasopharyngeal carcinoma.